Press Releases

 Filter by Provider

Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), a leading work management platform for human + AI collaboration, announced today that it will release financial results for the third quarter fiscal year 2026 on Tuesday, December 2, after the close of the U.S. markets.

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for the third quarter ended September 30, 2025, compared to $709 million for the same period of 2024.

CINCINNATI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Mobile Infrastructure Corporation (NASDAQ: BEEP), the nation’s only publicly traded owner of parking infrastructure, will issue its third quarter 2025 earnings release after the U.S. market closes on Monday, November 10, 2025.

All results reported are for continuing operations, unless otherwise noted.

Club Pilates – the largest Pilates brand globally– unveiled today its first national brand campaign, “Every Body Club Pilates,” a bold invitation to join the movement that’s always welcomed everyone: “Pilates is for every BODY.” The fully integrated campaign is now live nationwide, aiming to reframe Pilates for today’s culture by centering strength and accessibility for all ages, body types, and experience levels.

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

PEMBROKE, Bermuda, Nov. 03, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported a net loss from continuing operations available to common shareholders of $0.4 million, or ($0.01) per diluted share, compared to a net loss from continuing operations available to common shareholders of ($40.7 million), or ($1.07) per diluted share, for the same 2024 period. Adjusted net operating income1 for the third quarter of 2025 was $17.4 million or $0.32 per diluted share, compared to ($28.2 million), or ($0.74) per diluted share, for the same 2024 period.

Highlights

MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (“Bill”) Plovanic, CFA, to its Board of Directors.

The Special Meeting of Shareholders reconvenes on November 7, 2025

ZoomInfo (NASDAQ: GTM), the Go-To-Market Intelligence Platform, today announced its financial results for the third quarter ended September 30, 2025.

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

Cambridge, Massachusetts, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, and members of senior management will be participating in a fireside chat and investor one-on-one meetings at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10th, 2025 in Boston, MA.

VISTA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, will report its fiscal first quarter 2026 results on Thursday, November 13, 2025, after market close. Krishna Vanka, Chief Executive Officer, and Kevin Royal, Chief Financial Officer, will host a conference call at 4:30 p.m. ET to discuss the Company’s financial results, followed by a question-and-answer session.

BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that management will participate in the following upcoming investor conferences in November 2025:

Validation study data show AdvanceAD-Tx can identify patients with AD who have a ‘JAKi responder profile’ and a superior response to JAKi therapies compared to Th2-targeted therapies

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in November:

STRATEGIC PORTFOLIO EXPANSION AND STRONG PRODUCT SEGMENT PERFORMANCE DROVE REVENUE AND EARNINGS GROWTH

Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors

HUNTSVILLE, Ala., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced that its Board of Directors declared a cash dividend for its fiscal fourth quarter of 2026 of $0.03 per share. The dividend will be paid on November 24, 2025, to stockholders of record as of November 17, 2025.

TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

DENVER, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Paul Taheri, MD, MBA as its Chief Medical Officer, effective November 3, 2025.

The virtual webcast will take place Wednesday, November 12, 2025, at 8 a.m. ET

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced financial results for the third quarter ended September 30, 2025.

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in a presentation at the Jefferies Global Healthcare Conference on Monday, November 17, at 2:30 p.m. GMT.  

BANNOCKBURN, Ill., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences:

Grateful for the warm reunions with friends old and new in Las Vegas! Specializing in the new energy sector, SUG showcased cutting-edge intelligent RV inverters and modular Home Energy Storage systems, redefining green energy living through innovative technology. Whether for cross-country road trips or household electricity needs, we deliver efficient and reliable clean energy solutions.

Kforce Inc. (NYSE: KFRC), a solutions firm that specializes in technology and other professional staffing services, today announced results for the third quarter of 2025.

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day.

TORRANCE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ high-voltage silicon carbide (SiC) power semiconductors, today announced unaudited financial results for the third quarter ended September 30, 2025.

RTO, also known as a Regenerative Thermal Oxidizer ，heats the organic waste gas to more than 760 ℃, so that the VOCs in the waste gas can be oxidized and decomposed into carbon dioxide and water. The high-temperature gas produced by oxidation flows through the special ceramic heat storage body to heat the ceramic body and "store heat". This "heat storage" is used to preheat the subsequent organic waste gas, thereby reducing fuel consumption for waste gas heating. The ceramic regenerator shall be divided into more than three (including three) zones or chambers, and each regenerator shall go through the procedures of heat storage, heat release and cleaning in turn, and work continuously again and again. After the "heat release" of the regenerator, some treated and qualified clean exhaust should be introduced immediately to clean the regenerator (to ensure that the VOC removal rate is more than 99%), and the "heat storage" procedure can be entered only after the cleaning is completed. RTO regenerative waste gas treatment equipment is characterized by low operation cost, high treatment efficiency of organic waste gas, adaptability to waste gas concentration of 1000~10000mg/m3, and decomposition efficiency of 99%--99.5%. It is currently the most economical and reliable Vocs Treatment technology that meets the strict emission standard of 50mg/m3, and has been widely used.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nidec (NJDCY) To Contact Him Directly To Discuss Their Options

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DETROIT, MICHIGAN - November 3, 2025 ( NEWMEDIAWIRE ) - As the markets enter the final stretch of 2025, investors are facing a high-stakes mix of macro uncertainty, sector rotation and elevated volatility. That calls for a protective stance, but traders can also use that volatility to their advantage. Join Direxion for an online bootcamp at 11 a.m. ET on Thursday, November 6, to learn how.

A simple device in your electrical panel, the RCD, is a lifesaver. It constantly monitors power flow and can cut electricity in a fraction of a second to prevent a fatal shock, protecting your family every day.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2025, and refined full year 2025 financial guidance.

Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2026 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $3.96 million in research since the program’s inception in 2010.

The world’s premier power and electrical event – ​ EP Shanghai International Power & Electrical Exhibition 2025​ – is coming to the ​National Exhibition and Convention Center (Shanghai)​​ from ​November 18-20, 2025​!

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration, has reported its financial and operational results for its fiscal second quarter ended September 27, 2025 (the “second quarter”) of fiscal year 2026.

Super Group (SGHC) Limited (NYSE: SGHC) (“SGHC”, the "Company" or “Super Group”), the parent company of Betway, a leading online sports betting and gaming business, and Spin, the multi-brand online casino, today announced its third quarter 2025 unaudited consolidated financial results.

SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended September 30, 2025.

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 27, 2025. The Company reported revenue of $1,049.5 million, GAAP diluted EPS of $0.83, and non-GAAP diluted EPS of $1.13.

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer.

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, will be presenting at 3 upcoming healthcare conferences.

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 90,750 common shares of the Company (the "Options") with an effective grant date of November 3, 2025. The Options have an exercise price equal to the closing price of MindMed’s common shares on the date of the grant, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in substantially equal monthly increments over the three-year period thereafter, subject to each employee’s continued employment.

NEW HAVEN, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company focused on delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Thursday, November 6, 2025, at 8:30 a.m. ET to discuss its third quarter 2025 financial results and provide a corporate update.

Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024;

– Phase 3 X-TOLE2 FOS topline data on track to read out early 2026 with patient randomization complete 

New collaboration brings together Rapid7’s SOC expertise with Microsoft’s security ecosystem to simplify operations, strengthen protection, and unlock new value for joint customers

Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma